Immunomodulation of cancer with activated cytotoxic leukocytes
Stevenson, H.C.; Stevenson, G.W.
Progress in Clinical and Biological Research 337: 435-438
1990
ISSN/ISBN: 0361-7742 PMID: 2191333 Document Number: 361419
Document emailed within 1 workday
Related Documents
Walle, A.J.; Wang, J.; Novogrodsky, A.; Suthanthiran, M.; Gordon, B.; Rubin, A.L.; Stenzel, K.H. 1988: Periodate and recombinant interleukin-2-activated autologous leukocytes can induce regression of metastases of renal cancer Cancer Detection and Prevention 12(1-6): 395-411Jonker, M.; van den Hout, Y.; Noort, R.C.; Versteeg-van der Voort Maarschalk, M.F.; Claas, F.H.; Woude, F.J.; Hollander, D.; Perico, N.; Remuzzi, G. 2001: Immunomodulation by intrathymic injection of donor leukocytes in rhesus monkeys Transplantation 72(8): 1432-1436
Sondel, P.M.; Hank, J.A.; Kohler, P.C.; Chen, B.P.; Sosman, J. 1989: "Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes Progress in Clinical and Biological Research 288: 151-160
Gautam, S.; Chikkala, N.; Ganapathi, R. 1992: Immunomodulation by adriamycin - effect on the production of cytotoxic and inflammatory antitumor immune-responses International Journal of Oncology 1(7): 799-805
Watabe, S.; Sendo, F.; Kimura, S.; Arai, S. 1984: Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432 Journal of the National Cancer Institute 72(6): 1365-1370
Wang, W.J.; Bai, J.Y.; Cheng, G.F.; Zhu, X.Y. 2001: Effects of musk glucoprotein on the function of rat polymorphonuclear leukocytes activated by IL-8 in vitro Zhongguo Zhong Yao Za Zhi 26(1): 50-53
Rodríguez Orozco, A.R.; Serriteño, N.M. 2005: Immunomodulation in cancer. what do we do and where do we go? Revista Alergia Mexico 52(2): 96-101
Myrianthefs, P.M.; Batistaki, C. 2005: Cancer cachexia and immunomodulation Journal of BUON: Official Journal of the Balkan Union of Oncology 10(2): 181-188
Wang, W.; Bai, J.; Cheng, G.; Zhu, X. 1998: Effects of the glucoprotein component of musk on functions of rat polymorphonuclear leukocytes activated by LTB4 in vitro Zhongguo Zhong Yao Za Zhi 23(4): 238-240 Inside Back Cover
Truitt, G.A.; Rich, R.R.; Rich, S.S. 1977: Regulation of cytotoxic lymphocyte responses in vitro by alloantigen-activated spleen cells Journal of Immunology 119(1): 31-37
Karelin, A.A.; Globa, A.G.; Demidova, V.S.; Marchuk, A.I. 1986: Formation of signal ATP in plasma membranes of polymorphonuclear leukocytes activated by formyl-methionyl-leucyl-phenylalanine Voprosy Meditsinskoi Khimii 32(5): 93-98
Sycheva, L.P.; Mikhaĭlova, R.I.; Beliaeva, N.N.; Zhurkov, V.S.; Iurchenko, V.V.; Savostikova, O.N.; Alekseeva, A.V.; Kribtsova, E.K.; Kovalenko, M.A.; Akhal'tseva, L.V.; Sheremet'eva, S.M.; Iurtseva, N.A.; Murav'eva, L.V.; Kamenetskaia, D.B. 2014: Study of cytogenetic and cytotoxic effect of non-contact electrochemically-activated waters in the five organs of rats Gigiena i Sanitariia 93(6): 46-51
Lussow, A.R.; Fanget, L.; Gao, L.; Buelow, R.; Pouletty, P. 1996: Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival Transplantation Proceedings 28(2): 571-572
Bishop, G.A.; Hall, B.M. 1987: Effect of immunosuppressives on gamma-interferon production, lymphocyte proliferation, and cytotoxic function of activated T lymphocytes Transplantation Proceedings 19(2): 2866-2868
Macphail, S.; Stutman, O. 1987: L3T4+ cytotoxic T lymphocytes specific for class i H-2 antigens are activated in primary mixed lymphocyte reactions Journal of Immunology 139(12): 4007-4015
Nieminen, P.; Saksela, E. 1985: Common precursor pool marker for allospecific (CTL) and nonspecific (NK and activated) cytotoxic cells in the bone marrow Journal of Immunology 134(2): 699-703
Scharovsky, O.G.; Matar, P.; Rozados, V.R.; Rico, M.ía.J.; Zacarías Fluck, M.F.; Mainetti, L.E.; Fernández Zenóbi, M.V.; Roggero, E.A.; Gervasoni, S.I.; Rossa, A.; Perroud, H.án.A.; Sánchez, A.M.; Celoria, G.C.; Font, M.ía.T. 2012: Immunomodulation and antiangiogenesis in cancer therapy. from basic to clinical research Medicina 72(1): 47-57
Sabalić, S.ćk.; Kovacević, D.; Glavić, Z.; Buković, D.; Despot, A.; Fajdić, J.; Lukac, J.; Seso, I. 2006: The immunomodulation effect of allogenic blood transfusion in colorectal cancer--a new approach Collegium Antropologicum 30(4): 885-893
Thiele, D.L.; Lipsky, P.E. 1986: Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets Journal of Immunology 137(4): 1399-1406
Itoh, K.; Tilden, A.B.; Balch, C.M. 1985: Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells Cancer Research 45(7): 3173-3178